GAITHERSBURG, Md., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a corporate overview at the 10th Annual Biotech Showcase, being held January 8-...Read More
Altamira Gold Corp Closes $1,933,000 Non-Brokered Private Placement Not For Distribution to United States Newswire Services nor For Dissemination in the United States Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), (“Altamira” or the “Com...Read More
(TheNewswire) Toronto, Canada and Lima, Peru / TheNewswire / December 12, 2017 – Alturas Minerals Corp. (the “Company” or “Alturas”) (TSX-V, BVL: ALT) announced today that it has entered into agreements to settle an aggregate of $826,134.24 of debt owed to certa...Read More
145 Patients to be enrolledData expected in the second quarter of 2018Study will be fully-funded by BARDA GAITHERSBURG, Md., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the Company has submitted an Investi...Read More
GAITHERSBURG, Md., Nov.21, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, president and chief executive officer of Altimmune, will present a corporate overview at the 29th Annual Piper Jaffray Conference, takin...Read More
VANCOUVER, Nov. 15, 2017 /CNW/ - The following issues have been halted by IIROC: Company: ALTAMIRA GOLD CORP TSX-Venture Symbol: ALTA Reason: At the Request of the Company Pending News Halt Time (ET): 1:16 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a s...Read More
Altamira Gold Corp Announces $2,000,000 Non-Brokered Private Placement NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") announces t...Read More
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2017) - Trading resumes in: Company: Altamira Gold Corp. TSX-V Symbol: ALTA Resumption Time (ET): 14:30 IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, u...Read More
VANCOUVER, Nov. 15, 2017 /CNW/ - Trading resumes in: Company: ALTAMIRA GOLD CORP TSX-Venture Symbol: ALTA Resumption (ET): 2:30 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure...Read More
Initiated a Phase 2 clinical trial with NasoVAX vaccine with initial data expected in first quarter 2018 Completed enrollment in its Phase 1 HepTcell clinical trial with data expected in fourth quarter 2017Conference call and webcast scheduled for Friday, November 10 at 8:30am ETGAITHERSBURG, Md...Read More
GAITHERSBURG, Md., Nov.02, 2017(GLOBE NEWSWIRE) --Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the three and nine months ended September 30, 2017 after the market close on Thursday, November 9, and host a c...Read More
Altamira Gold Corp. confirms depth extent extension of Baldo East zone and identifies two new parallel structures at the Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to provide additional re...Read More
Altamira Gold Corp. Announces Commencement of Drilling at Crepori Project, Brazil, and Management Changes Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to announce the commencement of diamond drilling at the Crepori...Read More
Altamira Clarifies Sampling Results at Crepori and Provides Update on Drill Program Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") at the request of IIROC, wishes to clarify certain disclosure in its September 26th, 2017 news rel...Read More
Surface Sampling at Crepori Project Identifies Additional High-Grade Zones with Values up to 148.2g/T Gold. Additional Ground Acquired Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to announce that it has received re...Read More
Altamira Gold Corp. Confirms No Material Change Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), (the "Company") is issuing this news release after consulting with the Investment Industry Regulatory Organization of Canada (IIROC) as it relates to recent tradin...Read More
60 Patients to be enrolledData expected in the first quarter of 2018 GAITHERSBURG, Md., Sept.20, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that they have been cleared by the FDA to initiate their Phase 2 clinical study of N...Read More
GAITHERSBURG, Md., Sept.19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the Ladenburg Thalmann 3rd Annual Healthcare C...Read More
Altamira Gold Corp. Announces Commencement of Drilling at Crepori Project, Brazil, and Management Changes Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), ("Altamira" or the "Company") is pleased to announce the commencement of diamond drilling at the Crepori...Read More
GAITHERSBURG, Md., Sept.06, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the Rodman & Renshaw 19th Annual Global Inves...Read More